Investors with a lot of money to spend have taken a bullish stance on Bristol-Myers Squibb BMY.
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with BMY, it often means somebody knows something is about to happen.
So how do we know what these investors just did?
Today, Benzinga's options scanner spotted 9 uncommon options trades for Bristol-Myers Squibb.
This isn't normal.
The overall sentiment of these big-money traders is split between 55% bullish and 33%, bearish.
Out of all of the special options we uncovered, 2 are puts, for a total amount of $147,500, and 7 are calls, for a total amount of $971,639.
Expected Price Movements
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $25.0 and $40.0 for Bristol-Myers Squibb, spanning the last three months.
Analyzing Volume & Open Interest
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Bristol-Myers Squibb's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Bristol-Myers Squibb's whale activity within a strike price range from $25.0 to $40.0 in the last 30 days.
Bristol-Myers Squibb Option Volume And Open Interest Over Last 30 Days
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BMY | CALL | TRADE | BULLISH | 01/16/26 | $9.65 | $9.0 | $9.55 | $35.00 | $577.7K | 620 | 803 |
| BMY | CALL | TRADE | BEARISH | 06/20/25 | $5.45 | $5.35 | $5.35 | $40.00 | $133.7K | 259 | 255 |
| BMY | PUT | TRADE | BULLISH | 03/21/25 | $1.38 | $1.23 | $1.22 | $35.00 | $122.0K | 3.1K | 1.0K |
| BMY | CALL | SWEEP | BULLISH | 01/16/26 | $9.55 | $9.45 | $9.51 | $35.00 | $83.3K | 620 | 183 |
| BMY | CALL | TRADE | BULLISH | 01/16/26 | $6.75 | $5.55 | $6.7 | $40.00 | $67.0K | 3.6K | 160 |
About Bristol-Myers Squibb
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.
In light of the recent options history for Bristol-Myers Squibb, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Present Market Standing of Bristol-Myers Squibb
- Trading volume stands at 3,946,292, with BMY's price up by 0.36%, positioned at $41.63.
- RSI indicators show the stock to be may be approaching oversold.
- Earnings announcement expected in 45 days.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Bristol-Myers Squibb options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
